Methyl succinate antagonises biguanide‐induced AMPK‐activation and death of pancreatic β‐cells through restoration of mitochondrial electron transfer
- 1 April 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 150 (8), 1031-1043
- https://doi.org/10.1038/sj.bjp.0707189
Abstract
Two mechanisms have been proposed to explain the insulin-sensitising properties of metformin in peripheral tissues: (a) inhibition of electron transport chain complex I, and (b) activation of the AMP activated protein kinase (AMPK). However the relationship between these mechanisms and their contribution to beta-cell death and dysfunction in vitro, are currently unclear. The effects of biguanides (metformin and phenformin) were tested on MIN6 beta-cells and primary FACS-purified rat beta-cells. Cell metabolism was assessed biochemically and by FACS analysis, and correlated with AMPK phosphorylation state and cell viability, with or without fuel substrates. In MIN6 cells, metformin reduced mitochondrial complex I activity by up to 44% and a 25% net reduction in mitochondrial reducing potential. In rat beta-cells, metformin caused NAD(P)H accumulation above maximal glucose-inducible levels, mimicking the effect of rotenone. Drug exposure caused phosphorylation of AMPK on Thr(172) in MIN6 cell extracts, indicative of kinase activation. Methyl succinate, a complex II substrate, appeared to bypass metformin blockade of complex I. This resulted in reduced phosphorylation of AMPK, establishing a link between biguanide-induced mitochondrial inhibition and AMPK activation. Corresponding assessment of cell death indicated that methyl succinate decreased biguanide toxicity to beta-cells in vitro. AMPK activation can partly be attributed to metformin's inhibitory action on mitochondrial complex I. Anaplerotic fuel metabolism via complex II rescued beta-cells from metformin-associated toxicity. We propose that utilisation of anaplerotic nutrients may reconcile in vitro and in vivo effects of metformin on the pancreatic beta-cell.Keywords
This publication has 69 references indexed in Scilit:
- Oral Antidiabetic AgentsDrugs, 2005
- AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanismsBiochemical and Biophysical Research Communications, 2004
- Prolonged culture in low glucose induces apoptosis of rat pancreatic β-cells through induction of c-mycBiochemical and Biophysical Research Communications, 2003
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- Cell Cycle Regulation via p53 Phosphorylation by a 5′-AMP Activated Protein Kinase Activator, 5-Aminoimidazole- 4-Carboxamide-1-β-d-Ribofuranoside, in a Human Hepatocellular Carcinoma Cell LineBiochemical and Biophysical Research Communications, 2001
- Effects of glibenclamide and metformin (alone or in combination) on insulin release from isolated human pancreatic isletsActa Diabetologica, 1997
- Co-secretion of amylin and insulin from cultured islet β-cells: Modulation by nutrient secretagogues, islet hormones and hypoglycemic agentsBiochemical and Biophysical Research Communications, 1991
- The effect of biguanides on secretion and biosynthesis of insulin in isolated pancreatic islets of ratsDiabetologia, 1972
- The effect of dimethylbiguanide on glucose tolerance, serum insulin and growth hormone in obese patientsDiabetologia, 1972
- Respiratory inhibition and hypoglycemia by biguanides and decamethylenediguanidineBiochimica et Biophysica Acta, 1958